Long-Term Hematologic Improvement in a Patient With Cytopenic Myelofibrosis Treated With Pacritinib

JCO Precis Oncol. 2023 Jan:7:e2200523. doi: 10.1200/PO.22.00523.
No abstract available

MeSH terms

  • Bridged-Ring Compounds
  • Humans
  • Primary Myelofibrosis* / complications
  • Primary Myelofibrosis* / drug therapy
  • Pyrimidines / therapeutic use
  • Thrombocytopenia*

Substances

  • 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
  • Bridged-Ring Compounds
  • Pyrimidines